The Asia Pacific Intracranial Aneurysm Market would witness market growth of 9.3% CAGR during the forecast period (2023-2030).
Integrating artificial intelligence (AI) and machine learning (ML) algorithms into diagnostic imaging and treatment planning processes is revolutionizing the management of these aneurysms. AI-powered tools can analyze complex imaging data, identify subtle features, predict aneurysm growth and rupture risk, and assist clinicians in decision-making, leading to more accurate diagnoses and personalized treatment recommendations. Additionally, bioengineering and biomaterials research are driving innovation in developing novel devices and implants for treating these aneurysms.
Furthermore, rehabilitation specialists, such as physical therapists, speech-language pathologists, and occupational therapists, play a vital role in the long-term care of these aneurysms. They develop personalized rehabilitation plans to optimize functional recovery, improve quality of life, and facilitate community reintegration following surgical or endovascular interventions.
According to the State Council of the People’s Republic of China, Chinese citizens aged 60 or older comprise 18.7 percent of the nation’s total population, an increase of 5.44 percentage points since the last census conducted in 2010. Likewise, the hospital sector in India was valued at INR 7940.87 Bn in FY21 in terms of revenue and is expected to reach INR 18,348.78 Bn by FY 2027. Presently, the diagnostics sector in India is assessed to be worth $4 billion. The organized sector occupies almost 25% of this segment (15% in laboratories and 10% in radiology). The telemedicine sector is India’s maximum potential eHealth segment, which is expected to reach $5.4 Bn by 2025. Hence, the growing elderly population and expanding hospital sector propel the market’s growth.
The China market dominated the Asia Pacific Intracranial Aneurysm Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $155.5 Million by 2030. The Japan market is registering a CAGR of 8.6% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 9.9% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Integrating artificial intelligence (AI) and machine learning (ML) algorithms into diagnostic imaging and treatment planning processes is revolutionizing the management of these aneurysms. AI-powered tools can analyze complex imaging data, identify subtle features, predict aneurysm growth and rupture risk, and assist clinicians in decision-making, leading to more accurate diagnoses and personalized treatment recommendations. Additionally, bioengineering and biomaterials research are driving innovation in developing novel devices and implants for treating these aneurysms.
Furthermore, rehabilitation specialists, such as physical therapists, speech-language pathologists, and occupational therapists, play a vital role in the long-term care of these aneurysms. They develop personalized rehabilitation plans to optimize functional recovery, improve quality of life, and facilitate community reintegration following surgical or endovascular interventions.
According to the State Council of the People’s Republic of China, Chinese citizens aged 60 or older comprise 18.7 percent of the nation’s total population, an increase of 5.44 percentage points since the last census conducted in 2010. Likewise, the hospital sector in India was valued at INR 7940.87 Bn in FY21 in terms of revenue and is expected to reach INR 18,348.78 Bn by FY 2027. Presently, the diagnostics sector in India is assessed to be worth $4 billion. The organized sector occupies almost 25% of this segment (15% in laboratories and 10% in radiology). The telemedicine sector is India’s maximum potential eHealth segment, which is expected to reach $5.4 Bn by 2025. Hence, the growing elderly population and expanding hospital sector propel the market’s growth.
The China market dominated the Asia Pacific Intracranial Aneurysm Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $155.5 Million by 2030. The Japan market is registering a CAGR of 8.6% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 9.9% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Medtronic PLC
- Stryker Corporation
- MicroPort Scientific Corporation
- Johnson & Johnson
- MicroVention, Inc. (Terumo Corporation)
- B.Braun Melsungen AG
- Integra LifeSciences Holdings Corporation
- Delta Surgical
- Penumbra, Inc.
Market Report Segmentation
By End-use- Hospitals
- Clinics
- Others
- Endovascular Coiling
- Flow Diverters
- Surgical Clipping
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Intracranial Aneurysm Market by End-use
Chapter 5. Asia Pacific Intracranial Aneurysm Market by Type
Chapter 6. Asia Pacific Intracranial Aneurysm Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Medtronic PLC
- Stryker Corporation
- MicroPort Scientific Corporation
- Johnson & Johnson
- MicroVention, Inc. (Terumo Corporation)
- B. Braun Melsungen AG
- Integra LifeSciences Holdings Corporation
- Delta Surgical
- Penumbra, Inc.
Methodology
LOADING...
